Showing results (161-170 of 428) with videos related to
Sort By:
Pageof 43
The American Journal of Psychiatry|September 1, 1975
Thyrotropin-releasing hormone in schizophreniaK L Davis, L E Hossister, P A BergerNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Depressive response to physostigmine challenge in borderline personality disorder patientsB J Steinberg, R Trestman, V Mitropoulou, et al.Psychiatry Research|April 1, 1982
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controlsL J Siever, T W Uhde, E K Silberman, et al.Psychiatry Research|April 29, 1999
Serum cholesterol and impulsivity in personality disordersA S New, E M Sevin, V Mitropoulou, et al.The American Journal of Psychiatry|June 1, 1984
Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjectsL J Siever, T W Uhde, D C Jimerson, et al.Psychopharmacology|January 1, 1985
The effect of clorgyline on noradrenergic functionR J Ross, M Scheinin, P Lesieur, et al.Biological Psychiatry|November 24, 1999
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's diseaseJ I Friedman, D N Adler, K L DavisPsychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E HollisterCurrent Eye Research|July 1, 1990
Hormonal stimulation of 12(R)-HETE, a cytochrome P450 arachidonic acid metabolite in the rabbit corneaK L Davis, M W Dunn, M L SchwartzmanJournal of the American Geriatrics Society|May 1, 1983
Neurotransmitter deficits in Alzheimer's disease: criteria for significanceB S Greenwald, R C Mohs, K L DavisPageof 43